Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

NICE against new indication for Novartis' Lucentis

NICE has come out against the use of Novartis' eye care drug Lucentis (ranibizumab injection) in new indication in England and Wales. ... NICE will now consult on its draft guidance for Lucentis, with final guidance likely to be published in March 2012.

Regeneron's eye disorder drug Eylea wins US approval

FDA licences Lucentis competitor to treat patients with wet age-related macular degeneration. ... Current treatments for the disorder include Lucentis (ranibizumab injection), which is marketed in the US by Genentech/Roche and elsewhere by Novartis.

Interview: Joseph Jimenez, Novartis

Interview: Joseph Jimenez, Novartis In 2010, we had 13 key product approvals and 16 major filings in pharma, including Gilenya, Lucentis and Afinitor," he points out. ... populations. "In Q2 alone, we had four major approvals and two major filings, including Afinitor, Arcapta Neohaler,

Currency rates affect Roche's Q3 results

Regionally, the company saw growth of 1 per cent in US pharmaceutical sales, driven mainly by Lucentis, Rituxan and Actemra, although sales in Western Europe decreased by 4 per cent.

Risk sharing: mitigate uncertainty

For example, Novartis agreed with the NHS in the UK to pay for the macular degeneration drug Lucentis in case the patient required more than 14 injections (dose-capping).

[ Previous 5 results ] 11 12 13 14 15 16 17 18 19 20 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...